Trial intelligence / Profile preview

Effect of exercise or metformin on nocturnal blood pressure in obese adolescents

2008-000461-28Phase 4Active

Sponsor
Karolinska Institutet
Start
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of metformin in obesity and cardiac event risk (3 arms), sponsored by Karolinska Institutet. Primary endpoint: Nocturnal blood pressure dipping after 12 months. Started Mar 2008; status: active.

02

Drugs

metformin
03

Conditions

obesitycardiac event risk

Beyond the preview

Go deeper on 2008-000461-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-000461-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call